maritide glp-1 Amgen's obesity drug may help patients keep the weight off MariTide: Amgen's Monthly GLP-1 Shot

Mild pruritus or localized erythema may require only reassurance

Patients should be counseled to recognize signs of allergic responses, including widespread rash, hives, facial swelling, or difficulty breathing, which require immediate medical attention

Emerging research on melanocortin-4 receptor (MC4R) agonists combined with GLP-1/GIP agonists has shown promise for enhanced weight loss and prevention of weight regain, potentially addressing the needs of patients who plateau on current monotherapy [53]

No class of medication has gotten more buzz in recent years than the glucagon-like peptide-1 (GLP-1) receptor agonist, better known by the brand names Ozempic, Wegovy, Zepbound or the generic name semaglutide or tirzepatide

doi:10.1126/scitranslmed.aan0972 13